NICODERM CQ 14 mg/24h (Nicotine PATCH, EXTENDED RELEASE) 14 mg/24h

NICODERM CQ 14 mg/24h is a transdermal patch designed to help manage nicotine dependence. This extended-release patch delivers nicotine steadily through the skin, aiding in smoking cessation efforts.

Strength

14 mg/24h

Pack Size

14 PATCH in 1 CARTON (0135-0195-05) / 24 h in 1 PATCH (0135-0195-08)

Manufacturer / TM Owner

Haleon US Holdings LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NICODERM CQ 14 mg/24h is used as part of a smoking cessation program. The patch provides a controlled release of nicotine to help reduce withdrawal symptoms and cravings, making it easier to quit smoking. It is typically used for individuals who smoke more than 10 cigarettes a day and are looking for a gradual way to reduce their nicotine intake.

Side Effects

Common effects of using NICODERM CQ 14 mg/24h may include skin irritation at the application site, headaches, nausea, and dizziness. Some users may also experience vivid dreams or sleep disturbances. These effects vary and are not experienced by everyone.

Precautions & Warnings

Before using NICODERM CQ 14 mg/24h, it is important to consult with a healthcare provider, especially if you have any medical conditions or are taking other medications. The patch should be applied to clean, dry skin and changed as directed. Avoid exposing the patch to high temperatures or prolonged sunlight.

Avoid Interactions

NICODERM CQ 14 mg/24h may interact with certain medications, including those metabolized by the liver. It is also advisable to avoid smoking while using the patch, as this can lead to excessive nicotine intake. Always consult a healthcare provider for personalized advice.

Frequently Asked Questions

NICODERM CQ 14 mg/24h is used to help manage nicotine dependence and aid in smoking cessation.

The patch delivers a controlled amount of nicotine through the skin to help reduce withdrawal symptoms and cravings.

If you have skin allergies, consult a healthcare provider before using NICODERM CQ 14 mg/24h to ensure it is safe for you.

If you experience side effects, discontinue use and consult a healthcare provider for further guidance.

The duration of use should be determined by a healthcare provider based on your individual needs and progress.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.